Abstract
The fruit of the pomegranate tree (Punica granatum L.) has recently attracted attention based on anecdotal evidence and studies suggesting that it possesses antioxidant, anti-inflammatory and anti-cancer properties. The pomegranate (literally translated as seeded apple) plant is a shrub that commonly grows 6–15 ft tall. The fruit is a berry (globose) that is 2–3 inches in diameter and reddish when fully mature. It is filled with crunchy and juicy seeds that are eaten and used for extracting the juice. However, industrial preparations use the whole fruit for juice extraction. Antioxidant activity of flavonoids extracted from pomegranate fermented juice showed strong activity close to that of green tea and significantly higher than that of red wine. Preclinical laboratory studies have suggested that pomegranate and its constituents possess cancer preventive properties against skin, prostate, breast, colon, and lung cancers. Epidemiological, clinical, and case-control studies have not been conducted for pomegranate; however, a phase II clinical trial was recently conducted in patients with rising prostate specific antigen (PSA), a clinical marker for prostate cancer. Pomegranate juice given to men with rising PSA following surgery or radiation offered positive and beneficially significant effects on PSA parameters, suggesting a potential of pomegranate derived products for prevention of human prostate cancer. This chapter will focus on the laboratory and some clinical evidence on the cancer preventive properties of the pomegranate.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Adams LS, Seeram NP, Aggarwal BB, Takada Y, Sand D, Heber D (2006) Pomegranate juice, total pomegranate ellagitannins, and punicalagin suppress inflammatory cell signaling in colon cancer cells. J Agric Food Chem 54:980–985
Adams LS, Zhang Y, Seeram NP, Heber D, Chen S (2010) Pomegranate ellagitannin-derived compounds exhibit antiproliferative and antiaromatase activity in breast cancer cells in vitro. Cancer Prev Res 3:108–113
Adhami VM, Khan N, Mukhtar H (2009) Cancer chemoprevention by pomegranate: laboratory and clinical evidence. Nutr Cancer 61:811–815
Adhami VM, Mukhtar H (2007) Anti-oxidants from green tea and pomegranate for chemoprevention of prostate cancer. Mol Biotechnol 37:52–57
Afaq F, Malik A, Syed D, Maes D, Matsui MS, Mukhtar H (2005b) Pomegranate fruit extract modulates UV-B-mediated phosphorylation of mitogen-activated protein kinases and activation of nuclear factor kappa B in normal human epidermal keratinocytes paragraph sign. Photochem Photobiol 81:38–45
Afaq F, Saleem M, Krueger CG, Reed JD, Mukhtar H (2005a) Anthocyanin- and hydrolyzable tannin-rich pomegranate fruit extract modulates MAPK and NF-kappaB pathways and inhibits skin tumorigenesis in CD-1 mice. Int J Cancer 113:423–433
Afaq F, Zaid MA, Khan N, Dreher M, Mukhtar H (2009) Protective effect of pomegranate-derived products on UVB-mediated damage in human reconstituted skin. Exp Dermatol 18:553–561
Albrecht M, Jiang W, Kumi-Diaka J, Lansky EP, Gommersall LM (2004) Pomegranate extracts potently suppress proliferation, xenograft growth, and invasion of human prostate cancer cells. J Med Food 7:274–283
Aviram M, Dornfeld L, Rosenblat M, Volkova N, Kaplan M, Coleman R, Hayek T, Presser D, Fuhrman B (2000) Pomegranate juice consumption reduces oxidative stress, atherogenic modifications to LDL, and platelet aggregation: studies in humans and in atherosclerotic apolipoprotein E-deficient mice. Am J Clin Nutr 71:1062–1076
1Ben Nasr C, Ayed N, Metche M (1996) Quantitative determination of the polyphenolic content of pomegranate peel. Z Lebensm Unters Forsch 203:374–378
Bin Hafeez B, Asim M, Siddiqui IA, Adhami VM, Murtaza I, Mukhtar H (2008) Delphinidin, a dietary anthocyanidin in pigmented fruits and vegetables: a new weapon to blunt prostate cancer growth. Cell Cycle 7:3320–3326
Boateng J, Verghese M, Shackelford L, Walker LT, Khatiwada J, Ogutu S, Williams DS, Jones J, Guyton M, Asiamah D, Henderson F, Grant L, DeBruce M, Johnson A, Washington S, Chawan CB (2007) Selected fruits reduce azoxymethane (AOM)-induced aberrant crypt foci (ACF) in Fisher 344 male rats. Food Chem Toxicol 45:725–732
Cerdá B, Espín JC, Parra S, Martínez P, Tomás-Barberán FA (2004) The potent in vitro antioxidant ellagitannins from pomegranate juice are metabolised into bioavailable but poor antioxidant hydroxy-6H-dibenzopyran-6-one derivatives by the colonic microflora of healthy humans. Eur J Nutr 43:205–220
Elswijk DA, Schobel UP, Lansky EP, Irth H, van der Greef J (2004) Rapid dereplication of estrogenic compounds in pomegranate (Punica granatum) using on-line biochemical detection coupled to mass spectrometry. Phytochemistry 65:233–241
Gil MI, Tomas-Barberan FA, Hess-Pierce B, Holcroft DM, Kader AA (2000) Antioxidant activity of pomegranate juice and its relationship with phenolic composition and processing. J Agric Food Chem 48:4581–4589
Grossmann ME, Mizuno NK, Schuster T, Cleary MP (2010) Punicic acid is an omega-5 fatty acid capable of inhibiting breast cancer proliferation. Int J Oncol 36:421–426
Hafeez BB, Siddiqui IA, Asim M, Malik A, Afaq F, Adhami VM, Saleem M, Din M, Mukhtar H (2008) A dietary anthocyanidin delphinidin induces apoptosis of human prostate cancer PC3 cells in vitro and in vivo: involvement of nuclear factor-kappaB signaling. Cancer Res 68:8564–8572
Hong MY, Seeram NP, Heber D (2008) Pomegranate polyphenols down-regulate expression of androgen-synthesizing genes in human prostate cancer cells overexpressing the androgen receptor. J Nutriochem 19:848–855
Hora JJ, Maydew ER, Lansky EP, Dwivedi C (2003) Chemopreventive effects of pomegranate seed oil on skin tumor development in CD1 mice. J Med Food 6:157–161
Jeune MA, Kumi-Diaka J, Brown J (2005) Anticancer activities of pomegranate extracts and genistein in human breast cancer cells. J Med Food 8:469–475
Jurenka JS (2008) Therapeutic applications of pomegranate (Punica granatum L.): a review. Altern Med Rev 13:128–144
Kasimsetty SG, Bialonska D, Reddy MK, Thornton C, Willett KL, Ferreira D (2009) Effects of pomegranate chemical constituents/intestinal microbial metabolites on CYP1B1 in 22Rv1 prostate cancer cells. J Agric Food Chem 57:10636–10644
Kawaii S, Lansky EP (2004) Differentiation-promoting activity of pomegranate (Punica granatum) fruit extracts in HL-60 human promyelocytic leukemia cells. J Med Food 7:13–18
Khan GN, Gorin MA, Rosenthal D, Pan Q, Bao LW, Wu ZF, Newman RA, Pawlus AD, Yang P, Lansky EP, Merajver SD (2009) Pomegranate fruit extract impairs invasion and motility in human breast cancer. Integr Cancer Ther 8:242–253
Khan N, Afaq F, Kweon MH, Kim K, Mukhtar H (2007b) Oral consumption of pomegranate fruit extract inhibits growth and progression of primary lung tumors in mice. Cancer Res 67:3475–3482
Khan N, Afaq F, Mukhtar H: (2008) Cancer chemoprevention through dietary antioxidants: progress and promise. Antioxid Redox Signal 10:475–510
Khan N, Hadi N, Afaq F, Syed DN, Kweon MH, Mukhtar H (2007a) Pomegranate fruit extract inhibits prosurvival pathways in human A549 lung carcinoma cells and tumor growth in athymic nude mice. Carcinogenesis 28:163–173
Kim ND, Mehta R, Yu W, Neeman I, Livney T, Amichay A, Poirier D, Nicholls P, Kirby A, Jiang W, Mansel R, Ramachandran C, Rabi T, Kaplan B, Lansky E (2002) Chemopreventive and adjuvant therapeutic potential of pomegranate (Punica granatum) for human breast cancer. Breast Cancer Res Treat 71:203–217
Kohno H, Suzuki R, Yasui Y, Hosokawa M, Miyashita K, Tanaka T (2004) Pomegranate seed oil rich in conjugated linolenic acid suppresses chemically induced colon carcinogenesis in rats. Cancer Sci 95:481–486
Koyama S, Cobb LJ, Mehta HH, Seeram NP, Heber D, Pantuck AJ, Cohen P (2010) Pomegranate extract induces apoptosis in human prostate cancer cells by modulation of the IGF-IGFBP axis. Growth Horm IGF Res 20:55–62
Kuiper JMGG, Lemmen JG, Carlsson B, Corton JC, Safe SH, van der Saag PT, van der Burg B, Gustafsson JÄ (1998) Interaction of estrogenic chemicals and phytoestrogens with estrogen receptor β. Endocrinology 139:4252–4263
Langley P (2000) Why a pomegranate? BMJ 321:1153–1154
Lansky EP, Harrison G, Froom P, Jiang WG (2005b) Pomegranate (Punica granatum) pure chemicals show possible synergistic inhibition of human PC-3 prostate cancer cell invasion across Matrigel. Invest New Drugs 23:121–122
Lansky EP, Jiang W, Mo H, Bravo L, Froom P, Yu W, Harris NM, Neeman I, Campbell MJ (2005a) Possible synergistic prostate cancer suppression by anatomically discrete pomegranate fractions. Invest New Drugs 23:11–20
Lansky EP (2006) Beware of pomegranates bearing 40% ellagic Acid. J Med Food 9:119–122
Larrosa M, Gonzalez-Sarrias A, Garcia-Conesa MT, Tomas-Barberan FA, Espin JC (2006a) Urolithins, ellagic acid-derived metabolites produced by human colonic microflora, exhibit estrogenic and antiestrogenic activities. J Agric Food Chem 54:1611–1620
Larrosa M, Tomás-Barberán FA, Espín JC (2006b) The dietary hydrolysable tannin punicalagin releases ellagic acid that induces apoptosis in human colon adenocarcinoma Caco-2 cells by using the mitochondrial pathway. J Nutriochem 17:611–625
Longtin R (2003) The pomegranate: nature’s power fruit? J Natl Cancer Inst 95:346–348
Malik A, Afaq F, Sarfaraz S, Adhami VM, Syed DN, Mukhtar H (2005) Pomegranate fruit juice for chemoprevention and chemotherapy of prostate cancer. Proc Natl Acad Sci USA 102:14813–14818
Malik A, Mukhtar H (2006) Prostate cancer prevention through pomegranate fruit. Cell Cycle 5:371–373
Mehta R, Lansky EP (2004) Breast cancer chemopreventive properties of pomegranate (Punica granatum) fruit extracts in a mouse mammary organ culture. Eur J Cancer Prev 13:345–348
Mertens-Talcott SU, Bomser JA, Romero C, Talcott ST, Percival SS (2005) Ellagic acid potentiates the effect of quercetin on p21waf1/cip1, p53, and MAP-kinases without affecting intracellular generation of reactive oxygen species in vitro. J Nutr 135:609–614
Mertens-Talcott SU, Percival SS (2005) Ellagic acid and quercetin interact synergistically with resveratrol in the induction of apoptosis and cause transient cell cycle arrest in human leukemia cells. Cancer Lett 218:141–151
Noda Y, Kaneyuki T, Mori A, Packer L (2002) Antioxidant activities of pomegranate fruit extract and its anthocyanidins: delphinidin, cyanidin, and pelargonidin. J Agric Food Chem 50:166–171
Pacheco-Palencia LA, Noratto G, Hingorani L, Talcott ST, Mertens-Talcott SU (2008) Protective effects of standardized pomegranate (Punica granatum L.) polyphenolic extract in ultraviolet-irradiated human skin fibroblasts. J Agric Food Chem 56:8434–8441
Pantuck AJ, Leppert JT, Zomorodian N, Aronson W, Hong J, Barnard RJ, Seeram N, Liker H, Wang H, Elashoff R, Heber D, Aviram M, Ignarro L, Belldegrun A (2006) PhaseII study of pomegranate juice for men with rising prostate-specific antigen following surgery or radiation for prostate cancer. Clin Cancer Res 12:4018–4026
Reed JD, Krueger CG, Vestling MM (2005) MALDI-TOF mass spectrometry of oligomeric food polyphenols. Phytochemistry 66:2248–2263
Rettig MB, Heber D, An J, Seeram NP, Rao JY, Liu H, Klatte T, Belldegrun A, Moro A, Henning SM, Mo D, Aronson WJ, Pantuck A (2008) Pomegranate extract inhibits androgen-independent prostate cancer growth through a nuclear factor-kappaB-dependent mechanism. Mol Cancer Ther 7:2662–2671
Sartippour MR, Seeram NP, Rao JY, Moro A, Harris DM, Henning SM, Firouzi A, Rettig MB, Aronson WJ, Pantuck AJ, Heber D (2008) Ellagitannin-rich pomegranate extract inhibits angiogenesis in prostate cancer in vitro and in vivo. Int J Oncol 32:475–480
Saruwatari A, Okamura S, Nakajima Y, Narukawa Y, Takeda T, Tamura H (2008) Pomegranate juice inhibits sulfoconjugation in Caco-2 human colon carcinoma cells. J Med Food 11:623–628
Schubert SY, Lansky EP, Neeman I (1999) Antioxidant and eicosanoid enzyme inhibition properties of pomegranate seed oil and fermented juice flavonoids. J Ethnopharmacol 66:11–17
Seeram NP, Adams LS, Henning SM, Niu Y, Zhang Y, Nair MG, Heber D (2005) In vitro antiproliferative, apoptotic and antioxidant activities of punicalagin, ellagic acid and a total pomegranate tannin extract are enhanced in combination with other polyphenols as found in pomegranate juice. J Nutriochem 16:360–367
Seeram NP, Aronson WJ, Zhang Y, Henning SM, Moro A, Lee RP, Sartippour M, Harris DM, Rettig M, Suchard MA, Pantuck AJ, Belldegrun A, Heber D (2007) Pomegranate ellagitannin-derived metabolites inhibit prostate cancer growth and localize to the mouse prostate gland. J Agric Food Chem 55:7732–7737
Sharma M, Li L, Celver J, Killian C, Kovoor A, Seeram NP (2010) Effects of fruit ellagitannin extracts, ellagic acid, and their colonic metabolite, urolithin A, on Wnt signaling. J Agric Food Chem 58:3965–3969
Sturgeon SR, Ronnenberg AG (2010) Pomegranate and breast cancer: possible mechanisms of prevention. Nutr Rev 68:122–128
Syed DN, Malik A, Hadi N, Sarfaraz S, Afaq F, Mukhtar H (2006) Photochemopreventive effect of pomegranate fruit extract on UVA-mediated activation of cellular pathways in normal human epidermal keratinocytes. Photochem Photobiol 82:398–405
Toi M, Bando H, Ramachandran C, Melnick SJ, Imai A (2003) Preliminary studies on the anti-angiogenic potential of pomegranate fractions in vitro and in vivo. Angiogenesis 6:121–128
Tran HN, Bae SY, Song BH, Lee BH, Bae YS, Kim YH, Lansky EP, Newman RA (2010) Pomegranate (Punica granatum) seed linolenic acid isomers: concentration-dependent modulation of estrogen receptor activity. Endocr Res 35:1–16
Zaid MA, Afaq F, Syed DN, Dreher M, Mukhtar H (2007) Inhibition of UVB-mediated oxidative stress and markers of photoaging in immortalized HaCaT keratinocytes by pomegranate polyphenol extract POMx. Photochem Photobiol 83:882–888
Acknowledgements
The original work from the author’s (H.M.) laboratory outlined in this chapter was supported by United States Public Health Service Grants R01 CA 78809 and RO1 CA 120451.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2011 Springer New York
About this chapter
Cite this chapter
Adhami, V.M., Khan, N., Mukhtar, H. (2011). Prevention of Cancer with Pomegranate and Pomegranate Anthocyanins. In: Seeram, N., Stoner, G. (eds) Berries and Cancer Prevention. Springer, New York, NY. https://doi.org/10.1007/978-1-4419-7554-6_11
Download citation
DOI: https://doi.org/10.1007/978-1-4419-7554-6_11
Published:
Publisher Name: Springer, New York, NY
Print ISBN: 978-1-4419-7553-9
Online ISBN: 978-1-4419-7554-6
eBook Packages: Biomedical and Life SciencesBiomedical and Life Sciences (R0)